FDA Approves New Drug for Hodgkin Lymphoma

News   Apr 20, 2017 | Original story from National Cancer Institute

 
FDA Approves Pembrolizumab for Hodgkin Lymphoma

Anatomical illustration of lymphoma. Credit: Terese Winslow

 
 
 

RELATED ARTICLES

Protein That Helps Keep Breast Cancer Dormant Identified

News

A protein kinase that stops breast cancer cells growing and spreading has been outlined in new research.

READ MORE

Anti-Inflammatory Pill Could Make Vaccines More Effective for the Elderly

News

By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.

READ MORE

Vaccines Are Not Protecting Farmed Fish From Disease

News

The vaccines used by commercial fish farmers are not protecting fish from disease, according to a new study. It showed vaccinated fish tend to show more symptoms when contracting diseases, with the health impacts and ultimately deaths occurring as if they’d never received a vaccine.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE